Literature DB >> 8685338

Recurrent angina pectoris in patients with internal mammary artery to coronary artery bypass: treatment with coil embolization of unligated side branches.

A Chavan1, A Mügge, C Hohmann, I Amende, T Wahlers, M Galanski.   

Abstract

PURPOSE: The purpose of the study was to evaluate the effect on the symptoms of transcatheter coil embolization of branches of the internal mammary artery.
MATERIALS AND METHODS: In five patients with coronary steal syndrome that was caused by preferential flow in large unligated side branches of the internal mammary artery, coil embolization of the side branches was performed with use of a coaxial microcatheter.
RESULTS: Anginal symptoms disappeared in three patients and were substantially reduced in one patient following the radiologic intervention. In the fifth patient, who had concomitant stenoses of other coronary vessels, only a moderate change in symptoms was noted. No complications occurred.
CONCLUSION: In patients with internal mammary artery to coronary artery bypass who experience recurrent angina pectoris caused by preferential flow in large, unligated side branches of the internal mammary artery, repeat surgery may be circumvented or simplified by transcatheter coil embolization, which can help treat the angina.

Entities:  

Mesh:

Year:  1996        PMID: 8685338     DOI: 10.1148/radiology.200.2.8685338

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  2 in total

1.  Transcatheter occlusion of a large intercostal side-branch of left internal mammary artery bypass with detachable platinum coils.

Authors:  Christian Apitz; Tobias Hoevelborn; Martin Beyer; Ludger Sieverding; Michael Hofbeck; Meinrad Paul Gawaz
Journal:  Clin Res Cardiol       Date:  2006-02-27       Impact factor: 5.460

2.  Recurrence of coronary-subclavian steal syndrome after successful angioplasty of malfunctioning arteriovenous fistula.

Authors:  Hyun-Jeong Han; Byung-Soo Kang; Yun-Hyeong Cho
Journal:  Korean Circ J       Date:  2012-11-28       Impact factor: 3.243

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.